about
Comprehensive review of BAP1 tumor predisposition syndrome with report of two new casesDiscussion of photoprotection, screening, and risk behaviors with children and grandchildren after melanoma genetic testing.Hereditary genodermatoses with cancer predispositionPerceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.Melanoma epidemiology and public health.Histologic features of melanoma associated with CDKN2A genotype.Rare presentations of primary melanoma and special populations: a systematic review.Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma.Selection criteria for genetic assessment of patients with familial melanomaCutaneous melanoma: family screening and genetic testing.Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.Utilizing of Adsorptive Transfer Stripping Technique Brdicka Reaction for Determination of Metallothioneins Level in Melanoma Cells, Blood Serum and Tissues.MELPREDICT: a logistic regression model to estimate CDKN2A carrier probabilityRegulation of the retinoblastoma proteins by the human herpesviruses.Genetic determinants of cutaneous melanoma predisposition.Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.Management of melanoma families.Outcomes of interest in evidence-based evaluations of genetic tests.A diagnostic algorithm for atypical spitzoid tumors: guidelines for immunohistochemical and molecular assessment.Physical and functional interaction of the p14ARF tumor suppressor with ribosomes.Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.Lentigos, Melanocytic Naevi and MelanomaIntention to Obtain Genetic Testing for Melanoma among Individuals at Low to Moderate Risk for Hereditary Melanoma
P2860
Q28397229-C28D3276-03CA-4049-BD57-0BFE00EB7C10Q30203298-E6799F6B-16AA-476B-B44F-A215D2FB77D1Q30470596-A0E28C9A-BD8E-4179-8762-917EEBFC220DQ33638941-0097FA3C-8459-42BE-B08F-364FE5307951Q34401911-D07E8B3D-5B8B-4ABB-819E-F1DC898C2631Q34605024-F5449F88-F198-44C5-A4DB-837975DB68C6Q35097007-0DFAB774-65F2-4F15-9B98-D793A3EAA114Q35147046-308CB932-4F93-40B7-864C-28C8E427AD81Q35680356-79EABF44-CE89-43BF-A71D-E3D6974CD204Q35840024-24FA9C4E-B722-41C6-AEDF-FA98DA284FCCQ36365453-6E53C90F-EC54-4B0F-830A-68E4DF4A9977Q36694476-38B3CB90-AA1B-40A0-A9F5-16DFF2133443Q36741769-489B50BA-C8E0-41D7-B48F-280D487F47A0Q36768291-493ACE53-8C43-44E1-A2AB-9A7A7E759747Q36909926-D0415C94-2D33-4F24-BBC8-1B7E914C4409Q36930086-FA3118F4-FCBB-4E9B-86D7-7B3970D3C205Q37085853-725C3620-7ACD-4164-8027-DD5E5FD9304AQ37137000-7029D89D-D148-4D62-AF81-309F5FC63364Q37324432-36BF8BFA-B17A-4DA8-B315-A122DCC8B5AFQ37328311-89B2DE74-4D77-449E-81E9-966AE1899C0DQ37684710-0E8FBD62-CF2F-40EF-955D-D50450604EA6Q38814312-4CFAF0E1-463F-48FA-88A4-4379E5CB9DBAQ40221220-21D234F9-B095-4A55-A451-65D6722603E3Q46735021-75359F75-BE4C-4D91-916B-3289906AD359Q56828381-85620F21-54F6-4E2B-9055-0A5607EBA3A6Q58179614-095EBC9A-17CC-420F-BFFF-10C6A8BD5D73
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Genetic testing for melanoma.
@ast
Genetic testing for melanoma.
@en
Genetic testing for melanoma.
@nl
type
label
Genetic testing for melanoma.
@ast
Genetic testing for melanoma.
@en
Genetic testing for melanoma.
@nl
prefLabel
Genetic testing for melanoma.
@ast
Genetic testing for melanoma.
@en
Genetic testing for melanoma.
@nl
P2093
P50
P1433
P1476
Genetic testing for melanoma
@en
P2093
Alisa Goldstein
Brigitte Bressac-de Paillerets
David Elder
David Hogg
Johan Hansson
Julia Newton Bishop
Margaret Tucker
Melanoma Genetics Consortium
Nicholas Hayward
Rona Mackie
P304
P356
10.1016/S1470-2045(02)00894-X
P577
2002-11-01T00:00:00Z